The sample set before and after QC.
a Number of samples removed for bad quality arrays, sex chromosome discrepancies or extremely high copy number b Sample sets have overlapping families due to re-genotyping after a sample failure or missing biomaterials at the first genotyping time. c These samples have been a part of previous studies by Girirajan et al. 2013 , Matsunami et al. 2013 The Kruskal-Wallis non-parametric test was used to assess the existence of batch or set effect in the AGRE data set. We used one affected per family and one unaffected sibling, if available. All results were calculated as each genotyping set as its own strata. Analyses for frequencies were done using general linear model with binomial distribution. The OR and 95% CI for averages were estimated from logistic regression model effect sizes and standard errors. Due to the variable family structures, the number of available samples for different types of analyses varied. The frequencies are reported as family based, one family contributing maximum of one additional value to the affected or unaffected sample column. All identified individuals with a hemizygous 2q24.1 (NR4A2) deletion in AGRE and the DECIPHER and ClinGen databases. n/a = no information available. All samples with 100kb CNVs in WWOX in AGRE are listed here with all the available phenotype information. Most individuals are in in normal IQ range, and values that indicate moderate to less severe phenotype. IID= Individual identifier, CNV= copy number variation type, Del = deletion, Dup = duplication, Status = affection status (affected/unaffected), Inheritance = inheritance pattern, parent of origin for the CNV, Phenotype = phenotype description: SRS = Social Responsiveness Scale normalized T value (parent evaluation), Raven's NVIQ = Raven's non-verbal intelligence quotient measurement, PPVT = Peabody Picture Vocabulary Test standardized score, FSIQ = full scale intelligence quotient measure, Vineland = Vineland adaptive behavior score.
